Holen Sie sich die Stockscreener-App
3.35
6.87%
-0.29
Geovax Labs Inc Aktie (GOVX) Neueste Nachrichten
GeoVax Labs (GOVX) Narrows Focus on Key Development Programs - GuruFocus
GOVX Faces 11% Decline Following Suspension of COVID Vaccine Ini - GuruFocus
GeoVax Labs (GOVX) Shifts Focus from COVID Vaccine to Smallpox P - GuruFocus
Why Is GOVX Stock Falling Today? - Yahoo Finance
GeoVax (GOVX) resale S-1 shows 7.6M warrant shares and tight cash runway - Stock Titan
GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R) - Yahoo Finance
How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks - Yahoo Finance
GOVX Jumps As GeoVax Wins Bullish Ebola Vaccine Call - timothysykes.com
WHO Africa Chief Warns It's A 'Big Mistake' To Underestimate Ebola Outbreak As Deadly Virus Spreads Beyond Congo - Benzinga
Geovax Labs Analyst Ratings and Price Targets | NASDAQ:GOVX - Benzinga
Geovax Labs Inc (GOVX) Stock Price, Quote, News & History - Benzinga
GOVX Stock Jumps As Noble Capital Targets $10 On Ebola Vaccine Hopes - StocksToTrade
GOVX Stock Jumps As Noble Capital Reaffirms $10 Target - timothysykes.com
GOVX Stock Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs Q1 2026 Earnings: Significant EPS Beat Drives Stock SurgeRevenue Surprise History - Newser
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Q1 2025 GeoVax Labs Inc Earnings Call Transcript - GuruFocus
Is GeoVax Labs (GOVX) Still a Buy After +15.92% Rally? 2026-05-20Trading Community - Newser
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats - Benzinga
GeoVax Highlights Need for Flexible Vaccine Platforms Amid Bundibugyo Ebola Outbreak - MEXC
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms - Yahoo Finance
GeoVax Labs Announces Private Placement Offering with Pre-Funded and Common Stock Purchase Warrants – Details and Agreements Included - Minichart
GeoVax Raises $3 Million via Private Placement Financing - TipRanks
GeoVax Raises $2.7 Million Net in Private Placement of Pre-Funded and Common Warrants - TradingView
GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing - Stock Titan
Why is GeoVax Labs stock falling Tuesday? - MSN
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Why Is GeoVax Labs Stock Falling Tuesday? - Benzinga
GOVX Stock Sees Volatile Spike As Traders Eye Momentum - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight - TechStock²
GOVX stock soars 80%: Retail traders are piling in as Ebola, hantavirus risks resurface - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
GeoVax Labs, Inc. announced that it has received $3 million in funding - marketscreener.com
GeoVax Raises $3 Million in Private Placement for Working Capital and General Corporate Purposes - MEXC
GeoVax Labs, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
GeoVax Labs (NASDAQ: GOVX) asks shareholders to permit issuance of warrants converting to shares - Stock Titan
GeoVax Highlights Need for Domestic MVA Vaccine Infrastructure Amid Global Health Emergencies - citybuzz -
GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease Threats - Yahoo Finance
GOVX Stock Rockets On Heavy Volume As Traders Pile In - StocksToTrade
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules - The Globe and Mail
GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update - Quiver Quantitative
$GeoVax Labs (GOVX.US)$ Never trapped - Moomoo
GOVX Stock Volatility Draws Trader Attention Amid Weak Fundamentals - timothysykes.com
All you need to know about GeoVax Labs (GOVX) rating upgrade to buy - MSN
GeoVax Jumps Pre-market as Traders Eye Biotech’s Mpox Vaccine Push - TechStock²
$GeoVax Labs (GOVX.US)$ [Sob][Sob] Made some profit but it was a hidden loss, thank you everyone - Moomoo
$GeoVax Labs (GOVX.US)$ thank you - Moomoo
$GeoVax Labs (GOVX.US)$ havent sell all yet :) - Moomoo
Roth MKM Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy - cnhinews.com
Armistice Capital reports 9.99% stake in GEOVAX Labs (GOVX) via Master Fund - Stock Titan
GeoVax Advances GEO-MVA Phase 3 Trial as First Quarter 2026 Loss Narrows - citybuzz -
GeoVax Reports Q1 2026 Net Loss $5.3M, Cash $1.3M, Advances GEO-MVA Phase 3 Plans - TradingView
GeoVax (GOVX) Q1 2026 loss steady as cash falls and GEO-MVA advances - Stock Titan
GeoVax Labs | 10-Q: Q1 2026 Earnings Report - Moomoo
GeoVax Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GeoVax (GOVX) Q1 2026 shows flat loss but cash only into June - Stock Titan
GeoVax Reports First Quarter 2026 Financial Results and Highlights GEO-MVA Phase 3 Trial Implementation Plans - Yahoo Finance
GeoVax Highlights Gedeptin’s Potential in Combination Immunotherapy for Cold Tumors - citybuzz -
GeoVax Labs (NASDAQ: GOVX) holders report 233,337 shares equal to 9.99% stake - Stock Titan
TradingKey - TradingKey
GeoVax Highlights Emerging Role of Gedeptin(R) in Combination Immunotherapy Strategies Targeting Immunologically Cold Tumors - Yahoo Finance
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):